Laboratorios Liomont, S.A. de C.V.

Laboratorios Liomont is a leading Mexican pharmaceutical company established in 1938, headquartered in Mexico City. The company specializes in the development, manufacturing, and commercialization of a wide range of prescription and over-the-counter (OTC) medications, including analgesics, antibiotics, antivirals, and treatments for chronic non-communicable diseases. Liomont has invested significantly in modernizing its infrastructure, including specialized facilities for biotechnology and injectable products. The company is actively expanding its capabilities through strategic international partnerships, including recent collaborations for mRNA vaccine technology transfer and biosimilar development, aiming to strengthen Mexico's health sovereignty and expand its global footprint.